IL108681A0 - Influenza vaccine compositions - Google Patents
Influenza vaccine compositionsInfo
- Publication number
- IL108681A0 IL108681A0 IL10868194A IL10868194A IL108681A0 IL 108681 A0 IL108681 A0 IL 108681A0 IL 10868194 A IL10868194 A IL 10868194A IL 10868194 A IL10868194 A IL 10868194A IL 108681 A0 IL108681 A0 IL 108681A0
- Authority
- IL
- Israel
- Prior art keywords
- vaccine compositions
- influenza vaccine
- influenza
- compositions
- vaccine
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/39—Medicinal preparations containing antigens or antibodies characterised by the immunostimulating additives, e.g. chemical adjuvants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/12—Viral antigens
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/12—Viral antigens
- A61K39/145—Orthomyxoviridae, e.g. influenza virus
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/10—Dispersions; Emulsions
- A61K9/127—Liposomes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
- A61K2039/525—Virus
- A61K2039/5252—Virus inactivated (killed)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
- A61K2039/55505—Inorganic adjuvants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
- A61K2039/55511—Organic adjuvants
- A61K2039/55555—Liposomes; Vesicles, e.g. nanoparticles; Spheres, e.g. nanospheres; Polymers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
- A61K2039/55511—Organic adjuvants
- A61K2039/55572—Lipopolysaccharides; Lipid A; Monophosphoryl lipid A
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/58—Medicinal preparations containing antigens or antibodies raising an immune response against a target which is not the antigen used for immunisation
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/70—Multivalent vaccine
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
- C12N2760/00011—Details
- C12N2760/16011—Orthomyxoviridae
- C12N2760/16111—Influenzavirus A, i.e. influenza A virus
- C12N2760/16134—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
- C12N2760/00011—Details
- C12N2760/16011—Orthomyxoviridae
- C12N2760/16211—Influenzavirus B, i.e. influenza B virus
- C12N2760/16234—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US2153593A | 1993-02-19 | 1993-02-19 | |
US11575093A | 1993-09-01 | 1993-09-01 |
Publications (1)
Publication Number | Publication Date |
---|---|
IL108681A0 true IL108681A0 (en) | 1994-05-30 |
Family
ID=26694802
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
IL10868194A IL108681A0 (en) | 1993-02-19 | 1994-02-17 | Influenza vaccine compositions |
Country Status (9)
Country | Link |
---|---|
EP (1) | EP0684838A1 (sl) |
AP (1) | AP431A (sl) |
AU (1) | AU6141094A (sl) |
CA (1) | CA2156525A1 (sl) |
IL (1) | IL108681A0 (sl) |
MA (1) | MA23118A1 (sl) |
MX (1) | MX9401225A (sl) |
SI (1) | SI9400085A (sl) |
WO (1) | WO1994019013A1 (sl) |
Families Citing this family (24)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB9105992D0 (en) * | 1991-03-21 | 1991-05-08 | Smithkline Beecham Biolog | Vaccine |
DK0689454T4 (da) * | 1993-03-23 | 2005-05-30 | Smithkline Beecham Biolog | Vaccinepræparater indeholdende 3-O-deacyleret monophosphoryl-lipid A |
UA56132C2 (uk) * | 1995-04-25 | 2003-05-15 | Смітклайн Бічем Байолоджікалс С.А. | Композиція вакцини (варіанти), спосіб стабілізації qs21 відносно гідролізу (варіанти), спосіб приготування композиції вакцини |
US6306404B1 (en) | 1998-07-14 | 2001-10-23 | American Cyanamid Company | Adjuvant and vaccine compositions containing monophosphoryl lipid A |
GB9820525D0 (en) * | 1998-09-21 | 1998-11-11 | Allergy Therapeutics Ltd | Formulation |
US6261573B1 (en) * | 1998-10-30 | 2001-07-17 | Avant Immunotherapeutics, Inc. | Immunoadjuvants |
AT407958B (de) * | 1999-02-11 | 2001-07-25 | Immuno Ag | Inaktivierte influenza-virus-vakzine zur nasalen oder oralen applikation |
US6635261B2 (en) | 1999-07-13 | 2003-10-21 | Wyeth Holdings Corporation | Adjuvant and vaccine compositions containing monophosphoryl lipid A |
GB9923176D0 (en) * | 1999-09-30 | 1999-12-01 | Smithkline Beecham Biolog | Novel composition |
AU2002254901A1 (en) * | 2001-02-23 | 2002-10-03 | Smithkline Beecham Biologicals S.A. | Influenza vaccine formulations for intradermal delivery |
AR032575A1 (es) * | 2001-02-23 | 2003-11-12 | Smithkline Beecham Biolog | Uso de una preparacion antigenica de gripe para la fabricacion de una vacuna intradermica de la gripe y estuche farmaceutico que comprende dicha vacuna |
WO2002087494A2 (en) * | 2001-04-27 | 2002-11-07 | Glaxosmithkline Biologicals, Sa | Novel vaccine |
ES2432655T3 (es) | 2004-09-09 | 2013-12-04 | Novartis Vaccines And Diagnostics Gmbh | Reducción de riesgos iatrogénicos potenciales asociados con antígenos de vacunas |
ES2542020T3 (es) | 2004-11-03 | 2015-07-29 | Novartis Vaccines And Diagnostics, Inc. | Vacunación antigripal |
KR101916787B1 (ko) | 2005-03-23 | 2019-01-24 | 글락소스미스클라인 바이오로지칼즈 에스.에이. | Cd4 t-세포 및/또는 개선된 b-메모리 세포 반응을 유도하는 인플루엔자 바이러스 및 수중유 에멀젼 애주번트의 용도 |
EP2043682B1 (en) | 2006-07-17 | 2014-04-02 | GlaxoSmithKline Biologicals S.A. | Influenza vaccine |
WO2008134830A1 (en) * | 2007-03-22 | 2008-11-13 | Fundação Butantan | Method to obtain monophosphoryl lipid a from bordetella pertussis as a by-product of the cellular pertussis vaccine production |
US9452209B2 (en) | 2007-04-20 | 2016-09-27 | Glaxosmithkline Biologicals Sa | Influenza vaccine |
US20110014230A1 (en) * | 2008-03-18 | 2011-01-20 | Novartis Ag | preparation of influenza virus vaccine antigens |
EP2614163B1 (en) | 2010-09-07 | 2016-01-06 | Novartis AG | Generic assays for detection of mammalian reovirus |
MX2016012166A (es) * | 2014-03-25 | 2017-03-15 | The Government Of The Us Secretary Of The Army | Metodos para mejorar la potencia de inmunoestimulacion de vacunas adsorbidas con sales de aluminio. |
KR20210031901A (ko) | 2018-07-10 | 2021-03-23 | 세퀴러스 피티와이 리미티드 | 응집체의 제거 |
CN112361796A (zh) * | 2020-11-13 | 2021-02-12 | 安徽省天长市周氏羊业有限公司 | 一种秸秆回收储存前破碎干燥装置 |
CN114989269B (zh) * | 2022-06-30 | 2023-09-19 | 天康制药股份有限公司 | 一种牛赤羽免疫原性抗原及疫苗 |
Family Cites Families (11)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
IL79114A (en) * | 1985-08-07 | 1990-09-17 | Allergan Pharma | Method and composition for making liposomes |
US5230899A (en) * | 1985-08-07 | 1993-07-27 | Smithkline Beecham Corporation | Methods and compositions for making liposomes |
US4912094B1 (en) * | 1988-06-29 | 1994-02-15 | Ribi Immunochem Research Inc. | Modified lipopolysaccharides and process of preparation |
JPH04500203A (ja) * | 1988-08-25 | 1992-01-16 | ザ リポソーム カンパニー,インコーポレイテッド | インフルエンザワクチンおよび新規なアジュバント |
DK425789A (da) * | 1988-08-31 | 1990-03-01 | Smithkline Beecham Corp | Vaccinale polypeptider |
AU640348B2 (en) * | 1988-08-31 | 1993-08-26 | Smithkline Beecham Corporation | Vaccinal Polypeptides |
EP0644201A1 (en) * | 1990-09-28 | 1995-03-22 | SMITHKLINE BEECHAM BIOLOGICALS s.a. | Derivatives of gpl60 and vaccines based on gpl60 or a derivative thereof, containing an adjuvant |
JPH06503821A (ja) * | 1990-12-20 | 1994-04-28 | スミスクライン・ビーチャム・バイオロジカルス(ソシエテ・アノニム) | B型肝炎表面抗原に基づくワクチン |
FR2671974A1 (fr) * | 1991-01-24 | 1992-07-31 | Pasteur Merieux Serums Vacc | Composition vaccinale contre la grippe, a effet synergique, contenant comme additif du core de virus grippal. |
GB9105992D0 (en) * | 1991-03-21 | 1991-05-08 | Smithkline Beecham Biolog | Vaccine |
EP0761231B1 (en) * | 1992-06-25 | 2000-01-12 | SMITHKLINE BEECHAM BIOLOGICALS s.a. | Vaccine composition containing adjuvants |
-
1994
- 1994-02-15 AU AU61410/94A patent/AU6141094A/en not_active Abandoned
- 1994-02-15 WO PCT/EP1994/000448 patent/WO1994019013A1/en not_active Application Discontinuation
- 1994-02-15 CA CA002156525A patent/CA2156525A1/en not_active Abandoned
- 1994-02-15 EP EP94908327A patent/EP0684838A1/en not_active Withdrawn
- 1994-02-17 MA MA23425A patent/MA23118A1/fr unknown
- 1994-02-17 IL IL10868194A patent/IL108681A0/xx unknown
- 1994-02-17 AP APAP/P/1994/000621A patent/AP431A/en active
- 1994-02-17 MX MX9401225A patent/MX9401225A/es unknown
- 1994-02-18 SI SI9400085A patent/SI9400085A/sl unknown
Also Published As
Publication number | Publication date |
---|---|
CA2156525A1 (en) | 1994-09-01 |
SI9400085A (en) | 1994-09-30 |
EP0684838A1 (en) | 1995-12-06 |
MA23118A1 (fr) | 1994-10-01 |
AP9400621A0 (en) | 1994-04-30 |
AU6141094A (en) | 1994-09-14 |
AP431A (en) | 1995-11-15 |
WO1994019013A1 (en) | 1994-09-01 |
MX9401225A (es) | 1994-08-31 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
IL109056A0 (en) | Vaccine compositions | |
AP9300502A0 (en) | Vaccine compositions | |
AP9400621A0 (en) | Influenza vaccine compositions | |
IL118004A0 (en) | Vaccine compositions | |
ZA961460B (en) | Vaccine compositions | |
AU1308495A (en) | Influenza vaccine | |
IL108915A0 (en) | Polynucleotide vaccine against influenza virus | |
ZA946262B (en) | Pharmaceutical compositions | |
IL128318A0 (en) | Vaccine composition against malaria | |
IL110201A0 (en) | Novel pharmaceutical compositions | |
HU9600207D0 (en) | Vaccine compositions | |
GB9317610D0 (en) | Pharmaceutical compositions | |
GB9326425D0 (en) | Vaccine compositions | |
GB9317504D0 (en) | Pharmaceutical compositions | |
HU9401771D0 (en) | Pharmaceutical compositions cintaining ipsapiron | |
GB9614618D0 (en) | Vaccine compositions | |
ZA941957B (en) | Vaccine compositions | |
GB9320454D0 (en) | Vaccine compositions | |
GB9601739D0 (en) | Vaccine Compositions | |
GB9425980D0 (en) | Vaccine compositions | |
GB9416097D0 (en) | Vaccine compositions | |
GB9403417D0 (en) | Vaccine compositions | |
ZA947878B (en) | Pharmaceutical compositions | |
IL94510A0 (en) | Influenza vaccine | |
GB9323754D0 (en) | Vaccine |